TransAct Technologies (TACT) Is Attractively Priced Despite Fast-paced Momentum

TransAct Technologies (TACT) is identified as an attractive investment opportunity, combining fast-paced price momentum with a reasonable valuation. The stock has demonstrated recent strength with a 2.9% four-week gain and a 5.3% twelve-week gain, alongside a beta of 1.27, contributing to a Zacks Momentum Score of 'A' and a Zacks Rank #2 (Buy) driven by upward earnings estimate revisions. Notably, TACT remains attractively priced with a price-to-sales ratio of 0.83, suggesting significant upside potential for investors seeking growth at a compelling valuation.

Analysis

TransAct Technologies (TACT) is presented as a compelling investment candidate at the intersection of momentum and value. The stock exhibits strong recent price performance, with a 2.9% gain over the last four weeks and a 5.3% gain over the past twelve, signaling sustained investor interest. This momentum is further quantified by a Zacks Momentum Score of 'A' and a beta of 1.27, indicating the stock is 27% more volatile than the broader market, a characteristic often sought by momentum-focused investors. Crucially, this price action is not baseless; it is supported by improving fundamentals, as evidenced by a Zacks Rank #2 (Buy) driven by upward revisions in analyst earnings estimates. Despite these positive momentum indicators, TACT appears fundamentally undervalued based on its Price-to-Sales ratio of 0.83x. This suggests that investors are paying only 83 cents for every dollar of the company's sales, indicating potential for significant price appreciation before the stock's valuation catches up to its growth trajectory.

Key Decisions for Investors

• Investors with a momentum or Growth at a Reasonable Price (GARP) strategy should consider TACT, as it meets the dual criteria of strong price momentum and an attractive valuation based on its P/S ratio of 0.83x.
• The investment thesis is highly dependent on continued upward earnings revisions; therefore, it is critical to monitor analyst estimate trends, as any negative revisions could quickly undermine the stock's 'Buy' rating and momentum.
• Given the stock's high beta of 1.27, investors should be prepared for heightened volatility and should size their positions accordingly, as the stock is likely to outperform in a rising market but underperform significantly during market downturns.